Artbio in a $132 million Series B deal co-led by Sofinnova Investments and B Capital, joined by F-Prime, Omega Funds, and Third Rock Ventures.

Round investors: B Capital F-Prime Capital Omega Funds Sofinnova Partners Qatar Investment Authority Alexandria Venture Investments Third Rock Ventures